ClinConnect ClinConnect Logo
Search / Trial NCT05880251

Operant Conditioning of Sensory Brain Responses to Reduce Phantom Limb Pain in People With Limb Amputation

Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · May 18, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Phantom Limb Pain Amputation Operant Conditioning Brain Computer Interface Electroencephalography Tactile Sense Instrumental Learning Event Related Potentials

ClinConnect Summary

This clinical trial is exploring a new way to help people who experience phantom limb pain (PLP) after losing a limb. Phantom limb pain is a common and often very painful condition affecting 60-90% of those with limb amputations, and it can last for years, impacting daily life and well-being. The study aims to train participants to change how their brains respond to sensory signals, which may help reduce this pain. Participants will receive real-time feedback about their brain activity during exercises designed to promote more normal brain responses, potentially leading to relief from their pain.

To join the study, participants need to be at least 18 years old and have experienced moderate to severe phantom limb pain for more than six months after their amputation. They should also be medically cleared to participate and able to follow study instructions. Unfortunately, individuals with certain medical conditions or cognitive difficulties may not be eligible. If you or someone you know is interested, the study is currently recruiting, and participants can expect to learn more about their brain activity while working towards reducing their phantom limb pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • An upper (or lower limb) amputation more than 6 months ago, that has produced a moderate to severe hand/arm (or foot/leg) phantom limb pain,
  • Male or female age 18 years or older,
  • Medical clearance to participate,
  • Reasonable expectation that ongoing medications, if any, will be maintained without change for at least 4 months from the start of the study,
  • Able to provide informed consent and to understand the study instructions,
  • Able to participate in the specific study procedures.
  • Exclusion Criteria:
  • Presence of other medically unstable and/or infectious condition (e.g., uncontrolled diabetes with recent weight loss, diabetic coma, frequent insulin reactions),
  • A cardiac condition (e.g., history of myocardial infarction or congestive heart failure),
  • Cognitive and/or attention difficulties affecting participant's ability to follow study directions,
  • Known skin disorders or damaged skin at the anticipated at the scalp for EEG recording (e.g., unhealed wounds, broken skin).
  • Metal implants above the chest

About Va Office Of Research And Development

The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.

Locations

Albany, New York, United States

Patients applied

0 patients applied

Trial Officials

Jodi A Brangaccio, PT

Principal Investigator

Albany VA Medical Center Samuel S. Stratton, Albany, NY

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported